Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
3,701	45.21799	0	male	0	35	1,747	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	0	97,645.375	61,893.25	null	16.5	white	20.699219	10	0.894897	0.856934	1	0	0	no	0.75	0.6	no dnr	35	65	12.798828	108	10	39.19531	null	null	null	0.899902	133	7.369141	null	null	null	null	0	no(M2 and SIP pres)	0
3,702	69.75494	1	male	1	9	9	COPD	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	28,524.625	18,503.4219	null	27.5	white	33.398438	45	0.600952	0.41095	1	0	0	no	null	null	dnr after sadm	9	103	20.699219	156	26	35	128.5625	null	null	1.299805	137	7.539062	null	null	null	null	3	<2 mo. follow-up	3
3,703	58.08398	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	26,848.094	18,352.8438	null	38	white	38.296875	63	0.47998	0.360962	5	0	0	no	null	null	no dnr	5	99	8.199219	130	40	37.59375	142.84375	null	26.898438	1.599854	134	7.299805	null	null	null	null	null	<2 mo. follow-up	2.318359
3,704	68.30896	1	male	0	15	266	Lung Cancer	Cancer	1	11	$11-$25k	0	19,022.094	13,289.7422	null	11.333328	black	15.5	11	0.728882	0.45697	1	0	0	metastatic	0.8	0.5	no dnr	15	81	4.399414	80	24	36.5	null	3.299805	0.5	1.099854	140	null	null	null	null	null	0	no(M2 and SIP pres)	0
3,705	49.56299	1	male	0	26	91	Lung Cancer	Cancer	1	12	$11-$25k	0	20,963.141	16,049.4844	null	5.5	white	23.597656	17	0.600952	0.282959	1	0	0	metastatic	0.6	0.5	no dnr	26	75	10.199219	100	24	35.29688	null	null	0.899902	0.899902	129	null	null	null	null	2	0	adl>=4 (>=5 if sur)	0
3,706	45.89499	1	female	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	$11-$25k	100	105,779.312	68,334.9375	null	32	white	19.296875	18	0.554932	0.441956	16	0	0	no	null	null	no dnr	14	153	6.599609	102	14	40	297.125	null	null	0.699951	142	7.399414	null	null	null	null	0	<2 mo. follow-up	0
3,707	57.51099	1	female	1	24	24	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	100	74,188.188	50,404.625	null	38.666657	black	36.5	59	0.08699	0.033997	3	0	0	no	0.05	0.000125	dnr after sadm	15	63	21.199219	80	11	36.69531	216	null	15.898438	2.199707	122	7.40918	null	null	null	null	0	<2 mo. follow-up	0
3,708	76.03595	1	male	0	68	1,485	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$11-$25k	0	194,034	119,902.875	null	23.5	white	31.199219	56	0.412964	0.292969	40	0	0	yes	0.9	0.9	no dnr	68	55	10.398438	126	28	38.5	272	3	1.199951	3	149	7.469727	null	null	null	null	6	adl>=4 (>=5 if sur)	6
3,709	72.86798	1	female	0	31	1,007	COPD	COPD/CHF/Cirrhosis	2	10	under $11k	0	70,304.062	49,123.8125	null	29	white	23.597656	36	0.679932	0.510986	4	0	0	yes	0.9	0.9	no dnr	31	131	14.798828	144	28	38.5	270	2.5	null	0.699951	132	7.439453	null	null	null	null	0	no(M2 and SIP pres)	0
3,710	46.15198	1	female	1	30	30	ARF/MOSF w/Sepsis	ARF/MOSF	2	15	>$50k	0	68,531.375	49,419.8125	null	20	white	23.796875	30	0.810913	0.747925	26	1	0	no	0.2	0.05	dnr after sadm	21	117	15.599609	74	22	36.09375	386.625	null	null	7.899414	132	7.369141	null	null	null	null	6	<2 mo. follow-up	6
3,711	72.94196	1	male	1	77	77	COPD	COPD/CHF/Cirrhosis	2	12	$25-$50k	0	224,667.25	154,288	null	32	white	29.398438	36	0.591919	0.40094	1	0	0	yes	0.6	0.6	dnr after sadm	60	127	19.597656	130	34	37.69531	260	2.5	null	0.799927	148	7.429688	null	null	null	null	0	adl>=4 (>=5 if sur)	0
3,712	56.01398	1	male	0	4	906	CHF	COPD/CHF/Cirrhosis	3	8	$11-$25k	0	4,446.297	3,174.543	null	3	white	20	21	0.884888	0.807983	1	0	0	no	null	null	no dnr	4	60	5.699219	124	24	36.09375	null	null	0.5	1.199951	142	null	null	null	null	0	1	no(M2 and SIP pres)	1
3,713	47.36798	1	male	1	12	12	Cirrhosis	COPD/CHF/Cirrhosis	1	10	under $11k	26	32,115.641	23,570.2656	null	40	white	33.5	54	0.498962	0.296997	1	0	0	no	0.2	0.1	dnr after sadm	12	109	10.798828	114	12	37.79688	433.3125	2	31.097656	1.599854	131	7.5	null	null	null	null	1	<2 mo. follow-up	1
3,714	60.39697	1	male	0	22	31	CHF	COPD/CHF/Cirrhosis	1	8	null	0	27,399.438	19,980.3125	null	19.666656	black	32.195313	45	0.695923	0.531982	1	0	0	no	0.6	0.4	dnr after sadm	17	61	5	118	25	35.59375	null	null	null	4.099609	130	null	null	null	null	null	null	<2 mo. follow-up	2.091309
3,715	66.35199	1	female	0	16	310	COPD	COPD/CHF/Cirrhosis	4	12	under $11k	0	26,706.297	18,707.6562	null	18	white	21.898438	29	0.836914	0.73291	1	0	0	no	0.9	0.7	no dnr	16	115	27.398438	114	26	38	210	null	0.399963	0.799927	140	7.399414	null	null	null	null	0	no(M2 and SIP pres)	0
3,716	46.133	0	male	0	65	1,740	CHF	COPD/CHF/Cirrhosis	0	12	$11-$25k	0	135,704.5	95,831.5	null	16.25	white	19.5	18	0.909912	0.8479	1	0	0	no	0.9	0.6	no dnr	65	63	10.298828	106	24	36.59375	252	null	0.699951	1.299805	149	7.449219	null	null	null	0	0	no(M2 and SIP pres)	0
3,717	61.33298	0	male	0	15	1,740	CHF	COPD/CHF/Cirrhosis	2	12	$25-$50k	0	22,090.984	16,710.5625	null	17.666656	white	38.5	56	0.455994	0.254944	1	0	0	yes	0.5	0.3	no dnr	15	53	6.599609	112	36	35.29688	210	null	null	2.099609	125	7.489258	null	null	null	null	0	no(M2 and SIP pres)	0
3,718	67.50195	1	male	1	95	95	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	null	null	null	47	white	43.09375	70	0.316956	0.203979	2	0	0	no	0.5	0.4	no dnr	95	44	14.298828	168	27	39	116.25	null	null	2.099609	142	7.319336	null	null	null	null	null	null	1.993652
3,719	60.03799	1	male	0	21	1,214	ARF/MOSF w/Sepsis	ARF/MOSF	0	6	$11-$25k	0	62,400.594	41,833.6875	null	46	white	41.898438	55	0.405945	0.286987	2	0	0	no	0.9	0.85	no dnr	21	50	5.899414	140	31	40.29688	116.3125	null	null	1.399902	128	7.419922	null	null	null	null	0	adl>=4 (>=5 if sur)	0
3,720	30.92999	0	female	0	9	1,735	ARF/MOSF w/Sepsis	ARF/MOSF	1	18	$11-$25k	0	17,066.641	12,493.8516	null	13.5	black	23.097656	31	0.894897	0.856934	2	0	0	no	0.8	0.7	no dnr	9	117	17.5	100	20	37.39844	495.1875	null	null	7.199219	136	7.419922	null	null	null	4	0	no(M2 and SIP pres)	0
3,721	68.53699	1	male	0	9	31	CHF	COPD/CHF/Cirrhosis	4	6	under $11k	0	11,333.148	9,014.3438	null	11.5	white	15.398438	32	0.894897	0.824951	1	1	0	no	null	null	no dnr	9	65	10.298828	70	28	38.39844	null	null	null	1.199951	135	null	null	null	null	1	0	<2 mo. follow-up	0
3,722	62.853	1	male	0	50	211	Coma	Coma	0	16	>$50k	100	67,972.5	48,889.6562	null	30	white	24.898438	35	0.202972	0.141998	1	0	0	no	0.1	0.001	dnr after sadm	16	130	14.5	116	8	37.79688	356.625	2.5	0.5	4.299805	137	7.369141	null	null	null	null	null	adl>=4 (>=5 if sur)	2.367188
3,723	84.79895	1	male	1	6	6	Coma	Coma	2	16	under $11k	100	14,790.844	11,221.7109	null	35	black	21.898438	32	0.096985	0.057999	1	0	1	no	0.2	0.1	no dnr	6	140	13.298828	124	9	36	280.9375	2.699707	1	1.199951	141	7.359375	null	null	null	null	7	<2 mo. follow-up	7
3,724	75.71295	1	male	0	14	477	Colon Cancer	Cancer	2	null	>$50k	26	21,044.891	14,540.7812	null	16	black	46	60	0.030998	0	1	1	0	metastatic	0.8	0.8	no dnr	14	127	7.599609	116	8	34	393.3125	2.299805	3.399902	2.599609	136	7.319336	null	null	null	1	2	no(M2 and SIP pres)	2
3,725	60.55298	1	male	0	38	1,529	ARF/MOSF w/Sepsis	ARF/MOSF	3	7	$11-$25k	0	139,645.375	93,788.5625	null	31.25	white	34.296875	79	0.635986	0.533936	1	1	0	no	null	null	no dnr	38	56	21.898438	150	38	40.19531	240	2	null	2.699707	151	7.40918	null	null	null	null	1	no(M2 and SIP pres)	1
3,726	62.87198	1	female	0	5	60	Colon Cancer	Cancer	1	13	$11-$25k	0	5,380.949	3,435.7266	null	11	white	23.097656	13	0.723999	0.448975	1	0	0	metastatic	0.8	0.1	no dnr	5	100	13.099609	84	20	36.89844	null	2.799805	0.399963	0.899902	135	null	null	null	null	0	null	null	0.4948
3,727	43.73199	1	female	0	10	811	Cirrhosis	COPD/CHF/Cirrhosis	2	13	under $11k	41	23,367.25	16,260.5391	null	21	white	17.097656	27	0.814941	0.699951	1	0	0	no	0.6	0.5	no dnr	10	121	5.699219	76	26	36.39844	376.625	2	2.399902	0.799927	140	7.439453	null	null	null	null	1	SIP>=30	1
3,728	72.64899	1	female	1	6	6	Coma	Coma	1	7	under $11k	94	18,816.297	13,245.6719	null	41	black	23.097656	36	0.163971	0.109985	2	0	0	no	0.01	0.000001	dnr after sadm	4	80	22.199219	126	32	38.09375	285	2.399902	0.399963	1.599854	134	7.40918	null	null	null	null	6	<2 mo. follow-up	6
3,729	44.50897	1	male	0	7	563	Colon Cancer	Cancer	1	13	$11-$25k	0	7,222.297	5,163.0391	null	7	black	13.898438	9	0.881958	0.73291	1	0	0	metastatic	0.9	0.7	no dnr	7	103	6.299805	64	16	37.29688	null	null	0.399963	1.099854	135	null	null	null	null	0	0	null	0
3,730	49.11398	1	female	1	4	4	Coma	Coma	0	16	null	100	13,132.547	10,200.2109	null	33	white	21.699219	31	0.435974	0.362	1	0	0	no	0	0	dnr after sadm	3	193	16.699219	68	16	38.5	296.625	null	0.399963	3.399902	148	7.639648	null	null	null	null	0	<2 mo. follow-up	0
3,731	61.33099	1	male	0	18	213	Lung Cancer	Cancer	2	10	$11-$25k	0	14,604.5	11,523.4062	null	10.666664	white	22.199219	18	0.600952	0.282959	1	0	0	metastatic	0.8	0.6	no dnr	18	93	9.5	124	28	36.79688	null	3.399902	0.299988	0.699951	140	null	null	null	null	2	2	adl>=4 (>=5 if sur)	2
3,732	75.33698	1	male	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	2	6	$11-$25k	0	null	null	null	48	white	32.5	52	0.428955	0.30896	7	0	0	yes	0.3	0.2	dnr after sadm	8	57	10	118	14	35.79688	140	null	0.199982	2.299805	139	7.469727	null	null	null	null	7	<2 mo. follow-up	7
3,733	63.87097	1	male	0	6	61	Colon Cancer	Cancer	1	null	null	0	5,620.898	3,797.3769	null	18	black	18.5	13	0.79895	0.572998	1	0	0	metastatic	0.1	0.001	no dnr	6	82	15.699219	60	20	35.79688	null	null	0.399963	1	143	null	null	null	null	null	null	null	1.759522
3,734	46.146	0	female	0	93	1,728	Coma	Coma	0	null	null	55	110,333.188	79,961.75	null	16.5	other	23.097656	35	0.637939	0.576904	1	0	0	no	0.5	0.4	dnr after sadm	12	114	22.699219	130	33	37.79688	226.65625	2.699707	1.599854	1.299805	143	7.479492	null	null	null	null	0	adl>=4 (>=5 if sur)	0
3,735	62.642	1	male	1	21	21	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	9	134,189.125	86,933.5625	null	32.666657	white	27.398438	45	0.642944	0.541992	29	0	0	no	0.5	0.5	dnr after sadm	16	73	7	72	32	35.69531	266.625	null	null	2.199707	126	7.539062	null	null	null	null	null	<2 mo. follow-up	3.343262
3,736	60.71198	1	male	0	13	610	COPD	COPD/CHF/Cirrhosis	1	11	under $11k	0	18,054.734	12,643.5312	null	28	white	28.796875	40	0.772949	0.638916	1	0	0	no	0.5	0.4	dnr after sadm	2	59	17.097656	128	29	35.59375	186.65625	null	null	0.799927	136	7.379883	null	null	null	0	0	no(M2 and SIP pres)	0
3,737	48.41599	1	male	0	5	256	Lung Cancer	Cancer	1	12	$11-$25k	0	6,101.648	3,718.8301	null	7	white	15.099609	11	0.776978	0.534912	1	0	0	metastatic	0.8	0.2	no dnr	5	113	14.298828	116	24	36.59375	null	3.899902	0.299988	0.899902	141	null	null	null	null	1	1	no(M2 and SIP pres)	1
3,738	79.33997	1	female	1	8	8	Coma	Coma	0	14	$11-$25k	61	16,749.594	11,828.3281	null	20.5	white	19.097656	21	0.401978	0.328979	1	0	0	no	0.2	0.15	dnr after sadm	5	110	15.699219	122	8	38.09375	340	null	0.899902	1.199951	140	7.479492	null	null	null	null	0	<2 mo. follow-up	0
3,739	80.10095	1	male	1	11	11	Coma	Coma	2	7	under $11k	44	29,686.375	21,820.5625	null	39.5	white	23.296875	38	0.358948	0.28595	1	1	0	no	0.1	0.001	dnr after sadm	2	103	16.796875	60	32	36.39844	283.3125	null	null	2.199707	138	7.429688	null	null	null	null	7	<2 mo. follow-up	7
3,740	83.02496	1	female	1	26	26	ARF/MOSF w/Sepsis	ARF/MOSF	1	7	under $11k	0	22,340.797	17,646.4531	null	13.5	black	20.199219	25	0.800903	0.734985	1	1	0	no	0.25	0.2	dnr after sadm	14	83	13.699219	76	22	36.29688	300	null	1.099854	1.699951	148	7.369141	null	null	null	null	0	<2 mo. follow-up	0
3,741	51.89899	0	male	0	10	1,718	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	>$50k	0	20,532.094	15,660.5156	null	20.5	white	26.699219	27	0.813965	0.751953	1	0	0	no	0.99	0.98	no dnr	10	99	15.699219	112	28	38.19531	180	null	null	1.399902	130	7.489258	null	null	null	0	0	no(M2 and SIP pres)	0
3,742	33.54999	1	female	0	6	191	Colon Cancer	Cancer	1	14	$25-$50k	0	7,093.848	5,116.8594	null	18	white	23.796875	24	0.780884	0.541992	1	0	0	metastatic	0.9	0.7	no dnr	6	73	15.199219	140	22	39.59375	null	null	null	0.599976	135	null	null	null	null	0	null	null	0.4948
3,743	21.043	1	female	1	4	4	Coma	Coma	0	15	$25-$50k	100	15,271.648	12,390.4844	null	42	white	53.398438	67	0.007	0.002	1	0	0	no	0.85	0.84	no dnr	4	46	12.298828	134	10	32.5	112.5	3.599609	0.799927	0.799927	175	7.599609	null	null	null	null	0	<2 mo. follow-up	0
3,744	46.09998	0	male	0	4	1,714	CHF	COPD/CHF/Cirrhosis	1	11	under $11k	0	2,824.148	2,343.2715	null	6	black	14.398438	6	0.939941	0.896973	1	0	0	no	0.95	0.6	no dnr	4	97	6.399414	72	24	36.5	null	null	1.399902	1.099854	141	null	null	null	null	0	0	no(M2 and SIP pres)	0
3,745	50.09998	0	male	0	3	1,714	Cirrhosis	COPD/CHF/Cirrhosis	2	4	$25-$50k	0	2,701.25	1,954.959	null	3	white	19.699219	19	0.843994	0.74292	1	0	0	no	null	0.5	no dnr	3	81	5	86	18	36.59375	null	3.599609	3.199707	1.299805	130	null	null	null	null	0	0	null	0
3,746	66.87695	1	male	0	16	189	CHF	COPD/CHF/Cirrhosis	0	5	$11-$25k	0	24,346.391	18,417.8594	null	11.666664	black	23.097656	30	0.819946	0.706909	1	0	0	no	0.85	0.8	no dnr	16	70	13.099609	120	22	36.5	null	null	null	1.599854	135	null	null	null	null	0	0	SIP>=30	0
3,747	58.55399	1	male	1	4	4	Lung Cancer	Cancer	1	11	$25-$50k	100	4,597.379	3,382.6074	null	17	white	38.59375	66	0	0	1	0	0	metastatic	0.5	0.3	dnr after sadm	2	73	0.399963	114	40	38.39844	252.375	2.199707	2.199707	0.899902	160	7.489258	null	null	null	null	7	<2 mo. follow-up	7
3,748	32.77499	1	female	0	41	989	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	null	26	72,100.438	52,992.1875	null	19	black	22.898438	31	0.80188	0.736938	30	0	0	no	0.25	0.15	no dnr	41	147	22.398438	108	8	38.5	388	null	2.099609	1.699951	148	7.369141	null	null	null	null	5	SIP>=30	5
3,749	79.82196	1	male	0	16	1,255	CHF	COPD/CHF/Cirrhosis	2	5	null	0	26,503.984	17,639.2812	null	16.666656	black	24.5	31	0.74292	0.594971	1	0	0	no	0.7	0.4	dnr after sadm	10	71	18	108	24	36.39844	280.9375	null	1.099854	1.399902	129	7.529297	null	null	null	3	null	no(M2 and SIP pres)	2.511099
3,750	66.97595	0	male	0	7	1,708	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	$11-$25k	0	17,114.547	12,349.8984	null	9.5	white	34.195313	36	0.522949	0.406982	7	0	0	no	null	null	no dnr	7	129	11.099609	100	20	37.69531	120.40625	null	null	5.199219	128	7.459961	null	null	null	null	0	no(M2 and SIP pres)	0
3,751	78.69397	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	100	17,514.391	10,762.4609	null	49	black	66.796875	100	0	0	1	0	0	yes	0	0	no dnr	3	27	9.699219	26	24	35.5	41	1.599854	1.099854	4.799805	164	7.149414	null	null	null	null	null	<2 mo. follow-up	2.666992
3,752	61.58499	0	female	0	12	1,708	Cirrhosis	COPD/CHF/Cirrhosis	2	12	$25-$50k	37	21,559.438	15,395.9688	null	28.5	white	22.296875	33	0.60498	0.415955	1	0	0	no	0.5	0.5	no dnr	12	109	9.398438	68	25	38.29688	336.625	3.399902	13.798828	0.799927	142	7.429688	null	null	null	1	0	no(M2 and SIP pres)	0
3,753	41.336	0	female	0	11	1,707	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	$25-$50k	0	14,625.898	10,672.5547	null	16.5	white	23	36	0.881958	0.840942	1	0	0	no	0.9	0.9	no dnr	11	77	11.5	110	31	36.19531	216.65625	2	0.5	0.699951	139	7.439453	null	null	null	0	0	no(M2 and SIP pres)	0
3,754	80.69299	1	female	1	23	23	Coma	Coma	0	8	null	100	19,765.344	16,017.7656	null	11.666664	black	25.199219	34	0.052994	0.028	2	0	0	no	0.1	0.001	dnr after sadm	2	117	16	120	30	38.79688	342.8125	null	null	0.599976	131	7.509766	null	null	null	null	1	<2 mo. follow-up	1
3,755	55.66299	0	male	0	4	1,706	CHF	COPD/CHF/Cirrhosis	3	0	under $11k	0	4,980.25	3,698.125	null	7	black	15.798828	17	0.917969	0.860962	1	0	0	no	0.9	0.75	no dnr	4	90	null	68	22	36.89844	null	3.399902	0.799927	1.5	139	null	null	null	null	0	null	null	0.4948
3,756	34.53	0	female	0	4	1,705	CHF	COPD/CHF/Cirrhosis	5	14	null	0	6,055.898	4,246.4609	null	6	black	18.699219	14	0.916992	0.859985	1	1	0	yes	1	0.5	no dnr	4	71	12.5	96	20	36.29688	null	null	1.399902	0.799927	141	null	null	null	null	0	0	no(M2 and SIP pres)	0
3,757	62.30499	1	male	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	49,924.438	33,067.125	null	44	white	29.398438	33	0.605957	0.5	6	0	0	yes	0.5	0.4	dnr after sadm	11	113	12.298828	106	28	38.5	117.5	null	1.399902	0.899902	130	7.449219	null	null	null	null	0	<2 mo. follow-up	0
3,758	78.58496	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	89	14,208.648	10,709.4922	null	37	white	84.390625	123	0	0	1	0	0	yes	null	null	dnr after sadm	2	0	80.09375	0	0	38.19531	53.32812	1.699951	2.5	7.399414	142	7.15918	null	null	null	null	null	<2 mo. follow-up	1.578613
3,759	73.56299	1	male	0	28	139	MOSF w/Malig	ARF/MOSF	2	null	null	0	54,476.031	36,734.5625	null	26.75	white	45.09375	86	0.122986	0.054993	1	0	0	yes	0.2	0.05	dnr after sadm	16	47	0.099991	190	32	36.09375	304	2.299805	0.299988	3.099609	143	7.40918	null	null	null	null	null	null	2.237793
3,760	57.793	1	female	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	100	null	null	null	47	white	74.59375	105	0	0	2	0	0	no	0.1	0.001	no dnr	3	23	6.699219	0	24	36	65	2.799805	5.5	6	164	7.129883	null	null	null	null	0	<2 mo. follow-up	0
3,761	41.16098	1	female	0	5	253	Colon Cancer	Cancer	1	null	null	0	4,960	3,366.8867	null	22	white	14.099609	5	0.884888	0.738892	1	0	0	metastatic	0.8	0.5	no dnr	5	85	7.5	78	16	36.39844	null	null	0.299988	0.799927	140	null	null	null	null	null	null	null	1.640869
3,762	62.81198	1	female	0	11	1,013	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	0	84,675.625	56,459.8438	null	17	white	28.398438	25	0.662964	0.565918	19	0	0	no	0.99	0.99	no dnr	11	61	14.798828	118	30	36.29688	190	2.5	null	0.5	134	7.439453	null	null	null	null	0	no(M2 and SIP pres)	0
3,763	62.70798	1	male	1	7	7	Lung Cancer	Cancer	1	14	$25-$50k	26	3,095.148	2,995.7598	null	6.5	white	16.597656	5	0.622925	0.309998	1	0	0	metastatic	0	0	dnr after sadm	1	80	9.898438	70	22	36	null	null	null	1	135	null	null	null	null	null	7	<2 mo. follow-up	7
3,764	50.29199	0	male	0	8	1,699	MOSF w/Malig	ARF/MOSF	1	16	>$50k	0	31,121.438	22,044.7344	null	22	white	26.398438	64	0.488953	0.370972	17	0	0	metastatic	1	0.5	no dnr	8	59	31	102	22	36.79688	396	1.599854	0.899902	7.199219	131	7.389648	null	null	null	0	0	no(M2 and SIP pres)	0
3,765	79.81696	0	male	0	10	1,697	COPD	COPD/CHF/Cirrhosis	1	20	$25-$50k	0	8,032.547	6,131.3477	null	10	white	18.097656	19	0.81189	0.694946	1	0	0	no	0.9	0.6	no dnr	10	97	11.599609	102	24	37.29688	247.59375	null	null	1.399902	138	7.329102	null	null	null	0	0	no(M2 and SIP pres)	0
3,766	63.64398	1	male	0	7	19	Colon Cancer	Cancer	1	16	$11-$25k	0	7,005.727	4,714.8516	null	10	white	32.5	31	0.495972	0.175995	1	0	0	metastatic	0.1	0.001	no dnr	7	113	11.099609	94	16	36.29688	null	2.599609	2	1.599854	131	null	null	null	null	null	4	<2 mo. follow-up	4
3,767	57.67297	0	male	0	9	1,697	COPD	COPD/CHF/Cirrhosis	4	16	$25-$50k	0	12,842.945	9,616.5078	null	16	white	31.398438	41	0.696899	0.531982	1	0	0	yes	0.6	0.5	no dnr	9	111	7.399414	110	21	36.69531	268	2.599609	null	2.799805	155	7.30957	null	null	null	null	4	no(M2 and SIP pres)	4
3,768	58.97598	1	male	0	26	329	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	null	9	209,815.5	142,808.875	null	35.75	white	27.296875	36	0.658936	0.560913	52	0	0	no	0.5	0.45	no dnr	26	73	18.296875	74	8	35.5	250	2.799805	null	8.099609	128	7.419922	null	null	null	null	0	SIP>=30	0
3,769	63.89899	1	female	1	17	17	ARF/MOSF w/Sepsis	ARF/MOSF	2	4	under $11k	0	68,388.125	44,266.1875	null	40	black	39.695313	61	0.442993	0.323975	2	1	0	no	0.6	0.5	no dnr	17	71	18.398438	110	40	35.79688	109.07812	null	null	2.299805	129	7.469727	null	null	null	null	0	<2 mo. follow-up	0
3,770	49.37198	1	male	0	7	324	Colon Cancer	Cancer	1	12	>$50k	0	7,472.5	5,169.1484	null	11	white	18	6	0.831909	0.632935	1	0	0	metastatic	0.8	0.5	no dnr	7	87	12.199219	56	16	36.59375	null	null	0.899902	0.799927	142	null	null	null	null	null	0	no(M2 and SIP pres)	0
3,771	68.20496	1	female	0	5	653	CHF	COPD/CHF/Cirrhosis	5	20	$25-$50k	0	6,022	4,329.4102	null	6	other	21.796875	41	0.830933	0.723999	1	1	0	no	null	null	no dnr	5	77	9.898438	102	20	36.19531	328.5625	3.599609	0.399963	2.399902	137	7.439453	null	null	null	1	2	no(M2 and SIP pres)	2
3,772	57.91397	1	female	0	24	837	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	9	38,281.625	27,834.9375	null	17.666656	hispanic	23	35	0.766968	0.691895	12	1	0	no	0.8	0.8	no dnr	24	119	14.199219	116	40	38.29688	213.3125	null	0.299988	0.799927	134	7.40918	null	null	null	null	2	null	2
3,773	68.37195	1	female	1	9	9	Coma	Coma	0	null	null	94	27,641.391	20,191.5	null	25.5	white	21.296875	19	0.231995	0.166992	3	0	0	no	null	null	dnr after sadm	4	110	9.699219	42	11	36.89844	250	null	null	0.599976	148	7.479492	null	null	null	null	0	<2 mo. follow-up	0
3,774	69.19897	0	male	0	37	1,682	Cirrhosis	COPD/CHF/Cirrhosis	3	null	null	0	91,875.625	64,329.7188	null	18.75	white	22.898438	34	0.588989	0.396973	12	0	0	no	0.6	0.6	no dnr	37	101	14.199219	108	22	36.79688	285.6875	2.399902	4.399414	1	148	7.55957	null	null	null	null	0	null	0
3,775	33.07898	1	male	1	34	34	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	$11-$25k	0	164,121.625	108,221.125	null	36.75	black	21.5	34	0.909912	0.87793	1	0	0	no	0.7	0.7	dnr after sadm	27	73	16.097656	72	10	36	228.5625	null	1	11.398438	133	7.319336	null	null	null	null	2	<2 mo. follow-up	2
3,776	72.64899	1	male	1	4	4	Coma	Coma	0	null	null	89	12,858.797	9,592.6719	null	37	white	17.699219	22	0.367981	0.294983	1	0	0	no	0.02	0.000008	dnr after sadm	4	120	13.199219	58	8	38.19531	197.125	null	null	1.299805	139	7.40918	null	null	null	null	null	<2 mo. follow-up	2.059082
3,777	69.01794	1	female	1	18	18	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	$11-$25k	0	57,983.438	39,160.5	null	18	white	20.5	19	0.80896	0.744995	5	0	0	no	0.8	0.65	no dnr	18	80	10	90	12	38.5	242.84375	null	null	2.099609	131	7.479492	null	null	null	null	1	<2 mo. follow-up	1
3,778	46.13797	0	male	0	81	1,681	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	9	165,522	113,269.062	null	41	white	31.597656	38	0.698975	0.60791	3	0	0	no	0.6	0.6	no dnr	81	151	22.597656	136	25	38.89844	116	3.299805	1.799805	0.899902	132	7.449219	null	null	null	null	null	null	2.230469
3,779	63.422	1	male	0	34	72	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	26	56,185.094	41,615.7812	null	25.75	white	37.398438	53	0.346985	0.22998	4	0	0	no	0.1	0.001	no dnr	34	126	8.798828	104	8	35.29688	142.84375	2.699707	4.399414	7	128	7.459961	null	null	null	null	null	null	2.65625
3,780	65.89496	0	female	0	29	1,679	Coma	Coma	0	9	$11-$25k	44	97,451.25	65,060.1875	null	30	white	16.199219	12	0.595947	0.530884	12	0	0	no	null	null	no dnr	29	125	10.599609	70	9	37.69531	331.375	null	null	0.699951	134	7.469727	null	null	null	null	0	adl>=4 (>=5 if sur)	0
3,781	64.10394	1	female	1	15	15	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	65,610.625	42,855.7812	null	47	white	24.5	23	0.787964	0.718994	2	0	0	no	0.6	0.5	dnr after sadm	13	65	15.298828	118	10	36.59375	167.5	3.199707	1	1	136	7.509766	null	null	null	null	0	<2 mo. follow-up	0
3,782	68.20496	1	female	0	15	1,495	COPD	COPD/CHF/Cirrhosis	1	16	null	0	89,705.938	60,473.875	null	25.666656	white	28.296875	33	0.625977	0.440979	42	0	0	no	0.8	0.6	no dnr	15	136	10.099609	54	26	36.19531	145.6875	3.199707	null	1.399902	133	7.359375	null	null	null	null	1	no(M2 and SIP pres)	1
3,783	42.88797	1	male	0	49	1,364	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	under $11k	9	107,267.375	73,935.5	null	26.5	black	29.898438	48	0.698975	0.608887	18	0	0	no	null	null	no dnr	49	127	28.097656	154	36	36.09375	226.65625	4.299805	4.699219	0.699951	138	7.439453	null	null	null	null	null	no(M2 and SIP pres)	2.874512
3,784	70.51599	1	female	0	8	60	Lung Cancer	Cancer	1	8	$11-$25k	0	7,154.898	5,441.2773	null	12.5	white	19.597656	11	0.638916	0.328979	1	0	0	metastatic	0.9	0.5	no dnr	8	97	8.298828	68	16	35.29688	null	null	0.299988	0.5	136	null	null	null	null	4	5	null	5
3,785	74.09998	1	female	0	16	78	Lung Cancer	Cancer	1	null	under $11k	0	11,191.844	8,596.3125	null	8.333328	black	19.398438	22	0.632935	0.32196	1	0	0	metastatic	0.5	0.2	dnr after sadm	2	137	13.699219	112	24	36.39844	null	null	0.299988	1	137	null	null	null	null	null	3	adl>=4 (>=5 if sur)	3
3,786	69.10895	1	male	0	34	37	ARF/MOSF w/Sepsis	ARF/MOSF	1	13	$25-$50k	9	53,654.719	39,518.2812	null	20	white	24.199219	34	0.625977	0.521973	15	0	0	yes	0.2	0.05	dnr after sadm	9	119	6.599609	110	50	38	296	null	null	0.599976	134	7.489258	null	null	null	null	0	<2 mo. follow-up	0
3,787	72.73895	0	male	0	7	1,673	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	$25-$50k	9	30,448.625	20,684.0625	null	21	white	21	36	0.753906	0.67688	7	0	0	no	null	null	no dnr	7	72	12.099609	64	30	36.79688	196.65625	3	null	1.399902	136	7.479492	null	null	null	1	0	no(M2 and SIP pres)	0
3,788	68.62994	1	male	1	33	33	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	$25-$50k	9	128,551.688	84,274.5625	null	46	white	37.195313	68	0.464966	0.345947	1	0	0	no	0.3	0.3	dnr after sadm	27	68	29.597656	144	40	40.59375	71	null	0.399963	1.599854	136	7.40918	null	null	null	null	0	<2 mo. follow-up	0
3,789	56.30899	1	female	0	12	86	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	16,926.094	12,640.9609	null	16	white	26.5	23	0.697998	0.60791	1	0	0	metastatic	0	0	no dnr	12	81	11.298828	118	32	37.09375	144.875	null	0.699951	1.099854	136	7.449219	null	null	null	1	2	adl>=4 (>=5 if sur)	2
3,790	75.12695	0	male	0	6	1,673	COPD	COPD/CHF/Cirrhosis	3	null	null	0	6,113.828	4,340.6133	null	20	black	19.199219	36	0.781982	0.650879	1	1	0	yes	null	null	no dnr	6	100	15	76	40	36	252.375	null	0.199982	0.799927	138	7.419922	null	null	null	null	6	adl>=4 (>=5 if sur)	6
3,791	65.80194	1	male	1	5	5	COPD	COPD/CHF/Cirrhosis	2	8	$11-$25k	26	5,412.527	3,704.7129	null	16	white	24.796875	18	0.665894	0.491943	1	0	0	yes	0.2	0.05	dnr after sadm	1	120	11.798828	124	24	35.09375	364	null	null	0.899902	135	7.25	null	null	null	0	0	<2 mo. follow-up	0
3,792	42.67798	1	male	0	6	869	CHF	COPD/CHF/Cirrhosis	4	10	under $11k	0	3,498.949	2,964.6816	null	9	black	21.898438	32	0.899902	0.830933	1	1	0	no	null	null	no dnr	6	97	7.599609	70	21	36.39844	357.125	null	1.199951	3.099609	134	7.389648	null	null	null	null	5	adl>=4 (>=5 if sur)	5
3,793	47.51797	1	female	0	8	226	Lung Cancer	Cancer	2	12	$25-$50k	0	10,569.695	7,576.1016	null	15.5	white	22	26	0.645996	0.338989	1	0	0	metastatic	0.9	0.9	no dnr	8	99	20.199219	74	10	36.69531	366.625	3.199707	0.5	0.699951	143	7.459961	null	null	null	0	0	no(M2 and SIP pres)	0
3,794	28.211	1	male	1	14	14	Coma	Coma	1	12	null	100	75,495.125	52,903.625	null	28	black	27.5	52	0.372986	0.299988	11	0	0	no	null	null	dnr after sadm	14	133	30.097656	126	12	38.69531	172.5	null	0.799927	1.899902	143	7.5	null	null	null	null	0	<2 mo. follow-up	0
3,795	77.89496	1	male	0	40	1,394	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	9	33,176.25	26,470.5781	null	15.5	black	29.296875	51	0.616943	0.511963	1	0	0	no	0.6	0.6	no dnr	40	60	27.597656	104	10	36.39844	263.3125	null	0.299988	5.799805	131	7.379883	null	null	null	null	null	no(M2 and SIP pres)	3.169434
3,796	56.12299	1	female	0	23	1,213	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$25-$50k	55	59,076.75	39,979.8125	null	31	white	33.09375	47	0.346985	0.230988	7	1	0	no	0.5	0.4	no dnr	23	61	10.199219	74	12	35.09375	83.0625	null	0.099991	4.899414	138	7.519531	null	null	null	null	1	no(M2 and SIP pres)	1
3,797	72.81897	1	male	0	20	194	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	51,952.594	36,315.0625	null	29.666656	white	32.195313	51	0.524902	0.409973	10	0	0	no	0.5	0.4	no dnr	20	59	15.798828	48	22	37.5	176.65625	null	null	2.899902	128	7.5	null	null	null	null	1	no(M2 and SIP pres)	1
3,798	74.80396	0	male	0	12	1,666	ARF/MOSF w/Sepsis	ARF/MOSF	1	4	$11-$25k	0	24,017.844	16,611.9844	null	18.5	white	17.296875	33	0.849976	0.797974	2	0	0	no	0.75	0.422	no dnr	12	64	7.599609	104	26	38.29688	220	null	0.5	1.399902	135	7.459961	null	null	null	0	0	no(M2 and SIP pres)	0
3,799	65.39099	1	male	1	7	7	MOSF w/Malig	ARF/MOSF	1	16	>$50k	37	65,632.688	41,967.875	null	47	white	48.695313	101	0.011	0.002	1	0	0	yes	0.5	0.3	dnr after sadm	6	45	0.099991	140	30	38.69531	230	1.199951	4.899414	2.599609	149	7.449219	null	null	null	null	6	<2 mo. follow-up	6
3,800	65.01794	1	male	1	3	3	Coma	Coma	1	14	>$50k	100	10,533.594	9,178.8906	null	28	white	36.5	57	0.004	0.001	1	0	0	yes	null	null	dnr after sadm	2	73	14.398438	0	0	35.89844	270	3.699707	2.199707	1.599854	149	7.459961	null	null	null	null	0	<2 mo. follow-up	0

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.